Coldstream Capital Management Inc Mirum Pharmaceuticals, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1 shares of MIRM stock, worth $44. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$44% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
225Shares Held
55.6MCall Options Held
2.6KPut Options Held
99.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$290 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$210 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$143 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$123 Million4.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$112 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.62B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...